Laboratory Products
New Rubella Virus-Like Particles Released
Aug 08 2019
The Native Antigen Company have announced the release of its Rubella virus-like particles (VLPs). The Rubella VLPs are a unique product in its new range of Rubella virus reagents, adding to the Company’s extensive selection of recombinant VLPs that offer researchers a reliable source of high-quality reagents for immunoassay development and manufacturing.
The Native Antigen Company specialises in the isolation and purification of native antigens and recombinant proteins from viral and bacterial pathogens. The first-to-market Rubella VLPs are expressed as recombinant proteins in the Company’s proprietary mammalian cell expression system. Recombinant expression of the Rubella structural polyprotein in HEK293 cells enables reliable and cost-effective production of high-quality VLPs, helping to ensure researchers achieve consistent and accurate results throughout immunoassay development and scale-up manufacturing. The Native Antigen Company also offers Rubella antigens, monoclonal antibodies and ELISAs for use in a wide range of research applications.
Dr Andy Lane, Commercial Director, The Native Antigen Company, said: “We are committed to expanding our product portfolio of reagents to facilitate cutting-edge vaccine and diagnostics research for infectious disease. Our reputation for delivering high-quality VLPs is growing and the addition of the Rubella VLPs to our new Rubella virus range means we are now able to offer researchers a consistent, well-defined and cost-effective alternative to current native Rubella products on the market, which are often difficult to produce and increasingly expensive.”
Rubella virus is the causative agent of a highly contagious acute self-limiting and generally mild disease known as Rubella or German measles, predominantly affecting children and young adults. However, when contracted during the first trimester of pregnancy, Rubella poses a significant health risk to the foetus. Rubella infection and vaccination provide >95% chance of developing lifetime immunity.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK